Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Windtree Therapeutics Inc (NASDAQ:WINT)

2.30
Delayed Data
As of Aug 26
 -0.10 / -4.17%
Today’s Change
1.42
Today|||52-Week Range
7.53
-23.20%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$19.1M

Company Description

Windtree Therapeutics, Inc. engages in the manufacture and development of products for infants and respiratory diseases. It focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. Its products include SURFAXIN and AFECTAIR. The company was founded by Evan Myrianthopoulos and James S. Kuo on November 6, 1992 and is headquartered in Warrington, PA.

Contact Information

Windtree Therapeutics, Inc.
2600 Kelly Road
Warrington Pennsylvania 18976-3622
P:(215) 488-9300
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Craig E. FraserPresident, Chief Executive Officer & Director
John Andrew TattoryChief Financial Officer, Treasurer & Senior VP
Mary B. TempletonSecretary, Senior Vice President & General Counsel
Steven G. SimonsonChief Development Officer & Senior Vice President
Kathryn A. ColeSenior Vice President-Human Resources